875.1 Da
C48H74O14
Soluble in ethanol, methanol, DMF or DMSO
-20°C
Description
epi-Ivermectin B1a is a base-catalysed intermediate in the decomposition of ivermectin. epi-Ivermectin B1a is formed by epimerisation at the 2-position which ultimately rearranges irreversibly to the isomeric alkene analogue, Δ2-ivermectin B1a. Despite the importance of ivermectin as an anthelmintic in animal health, there are no published reports of the biological activity or the levels of epi-ivermectin B1a in animals or the environment.
References
• Base-catalyzed isomerization of avermectins
Not for human therapeutic use or for medicinal purposes. For research applications only.
0.1 lbs
Research or further manufacturing use only, not for food or drug use.
